Clinical Trials Browser

Phase 2 × Neoplasms × Arsenic Trioxide × Clear all

NCT06088030 2024-01-03

Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer

Phase 2 Recruiting

Neoplasms, Li-Fraumeni Syndrome

NCT04695223 2021-01-06

Arsenic Trioxide for Structural p53 Mutations

Phase 2 Unknown

Neoplasms

NCT00250042 2011-09-20

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Neoplasms